These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 11981764)
41. Therapeutic effect of AdCMVCD/5-FC system and metabolism of 5-FC in the treatment of human tongue squamous cell carcinoma. Wang A; Huang H; Li S Chin Med J (Engl); 2003 Feb; 116(2):248-52. PubMed ID: 12775241 [TBL] [Abstract][Full Text] [Related]
42. Total vascular exclusion of the liver enhances the efficacy of retroviral-mediated associated thymidine kinase and interleukin-2 genes transfer against multiple hepatic tumors in rats. Alves A; Charre L; Panis Y; Cardoso J; Fabre M; Brisson E; Houssin D; Soubrane O; Klatzmann D Surgery; 2003 Jun; 133(6):669-77. PubMed ID: 12796736 [TBL] [Abstract][Full Text] [Related]
43. A first step in the development of gene therapy for colorectal carcinoma: cloning, sequencing, and expression of Escherichia coli cytosine deaminase. Austin EA; Huber BE Mol Pharmacol; 1993 Mar; 43(3):380-7. PubMed ID: 8450832 [TBL] [Abstract][Full Text] [Related]
44. Cancer-specific killing by the CD suicide gene using the human telomerase reverse transcriptase promoter. Liu J; Zou WG; Lang MF; Luo J; Sun LY; Wang XN; Qian QJ; Liu XY Int J Oncol; 2002 Sep; 21(3):661-6. PubMed ID: 12168115 [TBL] [Abstract][Full Text] [Related]
45. Multimodality therapy with a replication-conditional herpes simplex virus 1 mutant that expresses yeast cytosine deaminase for intratumoral conversion of 5-fluorocytosine to 5-fluorouracil. Nakamura H; Mullen JT; Chandrasekhar S; Pawlik TM; Yoon SS; Tanabe KK Cancer Res; 2001 Jul; 61(14):5447-52. PubMed ID: 11454690 [TBL] [Abstract][Full Text] [Related]
46. [Gene therapy for murine liver cancer by adenovirus-mediated cytosine deaminase gene]. Sun W; Wei D; Tang Z; Chen S Zhonghua Gan Zang Bing Za Zhi; 2000 Oct; 8(5):282-4. PubMed ID: 11058952 [TBL] [Abstract][Full Text] [Related]
47. [Combined gene therapy for murine liver cancer with interleukin-18 and cytosine deaminase genes]. Sun W; Tang Z; Wei D; Tang Y; Chen S Zhonghua Gan Zang Bing Za Zhi; 2001 Oct; 9(5):300-2. PubMed ID: 11676879 [TBL] [Abstract][Full Text] [Related]
48. Treatment of microscopic pulmonary metastases with recombinant autologous tumor vaccine expressing interleukin 6 and Escherichia coli cytosine deaminase suicide genes. Mullen CA; Petropoulos D; Lowe RM Cancer Res; 1996 Mar; 56(6):1361-6. PubMed ID: 8640826 [TBL] [Abstract][Full Text] [Related]
49. Direct and bystander killing of sarcomas by novel cytosine deaminase fusion gene. Ramnaraine M; Pan W; Goblirsch M; Lynch C; Lewis V; Orchard P; Mantyh P; Clohisy DR Cancer Res; 2003 Oct; 63(20):6847-54. PubMed ID: 14583482 [TBL] [Abstract][Full Text] [Related]
50. [Anticancer effects of cytosine deaminase gene/5-fluorocytosine therapies to ovarian cancer in vivo]. Yao Y; Peng Z; Wang H; Li Q; Liu S Zhonghua Fu Chan Ke Za Zhi; 2002 Apr; 37(4):195-7. PubMed ID: 12133407 [TBL] [Abstract][Full Text] [Related]
51. Tumor-targeted Salmonella expressing cytosine deaminase as an anticancer agent. King I; Bermudes D; Lin S; Belcourt M; Pike J; Troy K; Le T; Ittensohn M; Mao J; Lang W; Runyan JD; Luo X; Li Z; Zheng LM Hum Gene Ther; 2002 Jul; 13(10):1225-33. PubMed ID: 12133275 [TBL] [Abstract][Full Text] [Related]
52. Tumor recurrence after partial hepatectomy for liver metastases in rats: prevention by in vivo injection of irradiated cancer cells expressing GMCSF and IL-12. Aussilhou B; Panis Y; Alves A; Nicco C; Klatzmann D J Surg Res; 2008 Oct; 149(2):184-91. PubMed ID: 18499129 [TBL] [Abstract][Full Text] [Related]
53. [Antitumor activity of the recombinant rClone30-CD/5-FC system]. Lu Z; Zhang TY; Han MM; Bai FL; Wu W; Tian GY; Ren GP; Li DS Yao Xue Xue Bao; 2013 Feb; 48(2):261-8. PubMed ID: 23672024 [TBL] [Abstract][Full Text] [Related]
54. Antitumor effect of cytosine deaminase/5-fluorocytosine suicide gene therapy system mediated by Bifidobacterium infantis on melanoma. Yi C; Huang Y; Guo ZY; Wang SR Acta Pharmacol Sin; 2005 May; 26(5):629-34. PubMed ID: 15842785 [TBL] [Abstract][Full Text] [Related]
55. Quantitation of cytosine deaminase mRNA by real-time reverse transcription polymerase chain reaction: a sensitive method for assessing 5-fluorocytosine toxicity in vitro. Miller CR; Gustin AN; Buchsbaum DJ; Vickers SM; Manne U; Grizzle WE; Cloud GA; Diasio RB; Johnson MR Anal Biochem; 2002 Feb; 301(2):189-99. PubMed ID: 11814289 [TBL] [Abstract][Full Text] [Related]
56. Optimization of tumor-targeted gene delivery by engineered attenuated Salmonella typhimurium. Mei S; Theys J; Landuyt W; Anne J; Lambin P Anticancer Res; 2002; 22(6A):3261-6. PubMed ID: 12530073 [TBL] [Abstract][Full Text] [Related]
58. Regional delivery of an adenovirus vector containing the Escherichia coli cytosine deaminase gene to provide local activation of 5-fluorocytosine to suppress the growth of colon carcinoma metastatic to liver. Ohwada A; Hirschowitz EA; Crystal RG Hum Gene Ther; 1996 Aug; 7(13):1567-76. PubMed ID: 8864757 [TBL] [Abstract][Full Text] [Related]
59. [X-ray combined with cytosine deaminase suicide gene therapy enhances killing of colorectal carcinoma cells in vitro]. Chen G; Li S; Yu B; An P; Cai H; Guo W Zhonghua Wai Ke Za Zhi; 2002 Feb; 40(2):136-8. PubMed ID: 11955400 [TBL] [Abstract][Full Text] [Related]
60. Antitumor effect of a splenic injection of 5-fluorouracil on metastatic liver cancer in mice. Kanoh K; Shimura T; Suzuki H; Nomoto K; Asao T; Kuwano H J Pharmacol Exp Ther; 2004 Jan; 308(1):168-74. PubMed ID: 14569073 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]